Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
Long-Acting HIV Treatment Demonstrates Efficacy in People with Challenges Taking Daily Medicine as Prescribed
Long-acting antiretroviral therapy (ART) with cabotegravir and rilpivirine was superior in suppressing HIV replication compared to daily oral ART in people who had been unable to maintain viral suppression through an oral daily regimen.News Article updated on 02/28/2024 -
New Guidelines on Use of Statins in HIV Care
Read the new guidelines on use of statins in New Guidelines for Use of Statins by People with HIV to Prevent Cardiovascular Events (HIV.gov blog, 2/29/24).News Article updated on 03/01/2024 -
National Clinician Consultation Center
-
Syphilis Cases Continue to Climb
Syphilis cases continue to climb in the U.S. In April 2023, CDC reported a 32% increase in cases from 2020 to 2021 (133,954 to 176.713 cases). In 2022, cases had jumped yet again, to 203,500.News Article updated on 03/04/2024 -
Keep Track of CROI 2024: HIV.gov Blogs
CROI 2024 is underway. Keep track via HIV.gov blogs.News Article updated on 03/05/2024 -
HepVu Map on Hep C, Opioids
New data on Hepatitis C and other health indicators are available on HepVu.News Article updated on 03/08/2024 -
CROI 2024 Highlights from HIV.gov
CROI 2024 highlights from HIV.gov:News Article updated on 03/07/2024 -
Rapid ART Program Initiative for New Diagnoses
Rapid ART Program Initiative for New Diagnoses (RAPID) was designed to connect people with a new HIV diagnosis to ART within five days of diagnosis and within one day of their initial care visit. Linkage navigators counseled people on HIV care, identified an available clinician capable of immediately prescribing ART, scheduled the clinical appointment, and connected people to additional support services. RAPID led to a reduction in median time between initial diagnosis and both ART initiation and viral suppression.Resource from the RWHAP Best Practices Compilation updated on 07/04/2024
-
National ADAP Formulary Database
NASTAD’s National AIDS Drug Assistance Program (ADAP) Formulary Database provides an online, searchable, publicly available resource detailing state-by-state ADAP coverage of medications, including HIV antiretroviral (ARV) treatments, “A1” Opportunistic Infections (A1 OI) medications, treatments for hepatitis B and C, mental health and substance use treatment medications, and various vaccines and laboratory tests.
Resource updated 03/07/2024
-
EHE HIV Implementation Science Awards Track HRSA Initiatives
New grant awards for the latest round of funding of research on HIV interventions under the Ending the HIV Epidemic Initiative have been announced.News Article updated on 04/12/2024 -
Over 50,000 Health Professionals Trained: AETC 2022 Report
In 2021-2022, 56,383 health professionals received training in HIV clinical topics, provided by the HIV clinical training network under HRSA's Ryan White HIV/AIDS Program.News Article updated on 05/06/2024 -
Recap of Viral Suppression Improvements Under Impact Now Collaborative
CQII hosted a virtual Learning Session for our Impact Now Collaborative participants on February 6 and 7, 2024.News Article updated on 05/09/2024 -
POP-UP
POP-UP provides low-barrier comprehensive HIV primary care, substance use services, mental health services, and case management to people who are homeless and unstably housed with the goal of retaining clients in care and improving viral suppression. Among POP-UP participants, 44% who were unstably housed and not virally suppressed at the start of the study were virally suppressed 12 months after enrollment.Resource from the RWHAP Best Practices Compilation updated on 05/24/2024
-
HAB Updates its Mpox Info
HRSA's HIV/AIDS Bureau has updated its mpox resources.News Article updated on 05/23/2024 -
ADAP Performance Measures Revised 2024
Review of ADAP performance measures (released by HRSA's HIV/AIDS Bureau in 2024) and how they fit within recipients’ clinical quality management activities.Resource updated 05/29/2024
-
Rapid ART Start Protocol
The Rapid ART Start Protocol focuses on helping veterans with a new HIV diagnosis access ART and comprehensive treatment as soon as possible. A retrospective cohort study showed positive outcomes, including decreases in the time to first appointment, the time to ART initiation, and the time to reach viral suppression. In addition, patients receiving the intervention were more likely to reach viral suppression compared to patients seen pre-intervention at the same clinic.Resource from the RWHAP Best Practices Compilation updated on 06/21/2024
-
HIV Prevention and Care Improvements Summarized in CDC Surveillance Reports
In the U.S., the number of new HIV cases continue to decline, most people are linked to care within one month of their HIV diagnosis, and 69% reach viral suppression within 6 months of HIV diagnosis.News Article updated on 06/10/2024 -
Rise
Rise was implemented to address ART adherence issues among Black people with HIV. Through Rise, peer counselors used motivational interviewing techniques, leveraged Medication Event Monitoring System data to monitor and promote adherence, and connected participants to support services to address unmet needs. A randomized controlled trial showed that Rise participants were more likely to be adherent to ART than non-participants.Resource from the RWHAP Best Practices Compilation updated on 06/11/2024
-
National Ryan White Conference on HIV Care and Treatment
The 2024 National Ryan White Conference on HIV Care and Treatment theme is: Innovating to End the HIV Epidemic: Empowering Communities, Expanding Partnerships, Implementing Interventions.Event updated 07/01/2024